Worsening of soft tissue dystrophic calcification in an osteoporotic patient treated with teriparatide

被引:2
|
作者
Htet, T. D. [1 ,2 ]
Eisman, J. A. [1 ,2 ,3 ]
Elder, G. J. [1 ,2 ,4 ]
Center, J. R. [1 ,2 ,3 ]
机构
[1] St Vincents Hosp, Dept Endocrinol, Sydney, NSW, Australia
[2] Garvan Inst Med Res, Osteoporosis & Bone Biol Div, Sydney, NSW, Australia
[3] Univ New South Wales, Fac Med, Sydney, NSW, Australia
[4] Westmead Hosp, Dept Renal Med, Sydney, NSW, Australia
关键词
Dystrophic calcification; Osteoporosis; Teriparatide; NONUREMIC CALCIPHYLAXIS; CALCINOSIS CUTIS; DISEASES; THERAPY;
D O I
10.1007/s00198-017-4330-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Teriparatide, used for treatment of osteoporosis in patients at high risk of fracture risk, sometimes results in mild and transient hypercalcemia. There have been two recent reports of worsening dystrophic calcification in patients with autoimmune disorders following teriparatide treatment. We report a patient with severe osteoporosis and without a pre-existing autoimmune disorder, who developed symptomatic worsening of dystrophic calcification 4 months after teriparatide was initiated. Symptoms resolved within 1 week of teriparatide cessation.
引用
收藏
页码:517 / 518
页数:2
相关论文
共 50 条
  • [1] Worsening of soft tissue dystrophic calcification in an osteoporotic patient treated with teriparatide
    T. D. Htet
    J. A. Eisman
    G. J. Elder
    J. R. Center
    [J]. Osteoporosis International, 2018, 29 : 517 - 518
  • [3] Nonhealing venous ulcer in a patient with dystrophic soft tissue calcification
    Nasif, Abdullah
    Bauer, Karen
    Pasadyn, Vanessa
    Ahmed, Ayman
    Nazzal, Munier
    Osman, Mohamed
    [J]. JOURNAL OF VASCULAR SURGERY CASES INNOVATIONS AND TECHNIQUES, 2022, 8 (02): : 164 - 166
  • [4] SUBUNGUAL EXOSTOSIS IN AN OSTEOPOROTIC PATIENT TREATED WITH TERIPARATIDE
    Delivanis, Danae A.
    Bhargava, Amit
    Luthra, Pooja
    [J]. ENDOCRINE PRACTICE, 2013, 19 (05) : E115 - E117
  • [5] Worsening of calcinosis cutis with teriparatide treatment in two osteoporotic patients
    Echeverri, A. F.
    Ospina, F. E.
    Canas, C. A.
    Agualimpia, A.
    Suso, J. P.
    Tobon, G. J.
    Bonilla-Abadia, F.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (05) : 1049 - 1051
  • [6] Outcomes from a patient educational program in postmenopausal osteoporotic women treated with teriparatide
    Larrainzar, R.
    Aragon, A.
    Rentero, M.
    Lopez, A.
    Casillas, M.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S216 - S216
  • [7] TUMORAL SOFT TISSUE CALCIFICATION IN A DIALYSIS PATIENT
    Bucaloiu, I. D.
    Ashouian, N.
    Bonebrake, S. R.
    Bowen, T. R.
    Hartle, J. E.
    Norfolk, E. R.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) : A47 - A47
  • [8] Femoral strength in osteoporotic women treated with teriparatide or alendronate
    Keaveny, Tony M.
    McClung, Michael R.
    Wan, Xiaohai
    Kopperdahl, David L.
    Mitlak, Bruce H.
    Krohn, Kelly
    [J]. BONE, 2012, 50 (01) : 165 - 170
  • [9] SOFT TISSUE CALCIFICATION
    不详
    [J]. NUTRITION REVIEWS, 1959, 17 (05) : 157 - 159
  • [10] CALCIFICATION OF SOFT TISSUE
    BYWATERS, EG
    [J]. LANCET, 1962, 1 (7239): : 1105 - &